Cargando…
Dexmedetomidine-induced cardioprotection is mediated by inhibition of high mobility group box-1 and the cholinergic anti-inflammatory pathway in myocardial ischemia-reperfusion injury
OBJECTIVES: Dexmedetomidine (DEX) is a selective α2-adrenoceptor agonist that has anti-inflammatory and cardioprotective effects in myocardial ischemia/reperfusion (I/R) injury. The present study aimed to investigate the underlying mechanism by which DEX protects against myocardial I/R. METHODS: Spr...
Autores principales: | Zhang, Juan, Xia, Fan, Zhao, Haifeng, Peng, Ke, Liu, Huayue, Meng, Xiaowen, Chen, Chen, Ji, Fuhai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657822/ https://www.ncbi.nlm.nih.gov/pubmed/31344138 http://dx.doi.org/10.1371/journal.pone.0218726 |
Ejemplares similares
-
Vagal modulation of high mobility group box-1 protein mediates electroacupuncture-induced cardioprotection in ischemia-reperfusion injury
por: Zhang, Juan, et al.
Publicado: (2015) -
Role of high-mobility group box-1 in myocardial ischemia/reperfusion injury and the effect of ethyl pyruvate
por: LIN, YUNLING, et al.
Publicado: (2015) -
Preconditioning with high mobility group box 1 protein protects against myocardial ischemia–reperfusion injury
por: Hu, Xiaorong, et al.
Publicado: (2010) -
Novel Molecular Targets Participating in Myocardial Ischemia-Reperfusion Injury and Cardioprotection
por: Liu, Nan-Bo, et al.
Publicado: (2019) -
Protocol: dexmedetomidine on myocardial injury after noncardiac surgery—a multicenter, double-blind, controlled trial
por: Liu, Huayue, et al.
Publicado: (2023)